ADURO BIOTECH, INC. (46) | Business Finance (10)

Browse by Subcategory

Recent Contracts

Underwriting Agreement by and among Chinook Therapeutics, Inc. and SVB Securities LLC, Cantor Fitzgerald & Co., and William Blair & Company, L.L.C. as Representatives of the... (Filed With SEC on May 25, 2022)
Form of Pre-Funded Warrant (Filed With SEC on May 25, 2022)
SanReno Shareholders Agreement between the Registrant and SanReno Therapeutics Holdings Limited and SanReno Therapeutics (Hong Kong) Limited, a wholly owned subsidiary of SanReno... (Filed With SEC on March 17, 2022)
Form of Inducement Stock Option Agreement (Filed With SEC on April 7, 2021)
Contingent Value Rights Agreement, dated October 2, 2020, by and between Aduro Biotech, Inc. and Computershare Trust Company, N.A (Filed With SEC on November 5, 2020)
Note Termination Agreement, dated August 17, 2020, by and among Aduro Biotech, Inc., Chinook Therapeutics U.S., Inc. and certain investors named therein (Filed With SEC on August 18, 2020)
Form of Pre-Funded Warrant (Filed With SEC on November 10, 2021)
Underwriting Agreement by and among Chinook Therapeutics, Inc. and SVB Leerink and Evercore ISI, as Representatives of the several underwriters, dated November 9, 2021 (Filed With SEC on November 10, 2021)
Note Purchase Agreement, dated as of June 1, 2020, by and among Chinook Therapeutics U.S., Inc. and certain investors named therein (Filed With SEC on June 2, 2020)
Form of Convertible Promissory Note (Filed With SEC on June 2, 2020)